Getting it Right: The Reincarnation of the Astigmatic Keratotomy
July 30th 2010In a recent blog Dr Mark Packer said: “Somewhere in the back of my mind I keep a quote about perseverance and simplicity. It comes from an interview with Ernest Hemingway. The author was asked to explain why he rewrote the last page of A Farewell to Arms 39 times.”
Valproic acid shown to halt vision loss in patients with retinitis pigmentosa
July 28th 2010Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
Potential of microplasmin for nonsurgical treatment of vitreomacular adhesion
July 21st 2010Findings published in the July/August edition of Retina contain the results of a Phase II trial indicating that microplasmin was generally well tolerated, and support its potential for nonsurgical resolution of vitreomacular adhesion
Download an outreach toolkit for World Sight Day
July 20th 2010Glaucoma patient and director of the movie Going Blind, Joe Lovett and his team have developed a comprehensive Outreach Toolkit with details on how doctors can use the film to raise awareness of funding, educate students and patients or promote themselves.
European Commission's Scientific Committee is asking for ophthalmic experts' help
July 20th 2010The European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is seeking the assistance of ophthalmic experts who are interested in helping with its Health Effects Of Artificial Light working group.
Glaucoma Research Foundation receives $1.6 million gift
July 13th 2010The Glaucoma Research Foundation has received the largest single gift in its 32 year history. The staggering $1.6 million gift from the Melza M. and Frank Theodore Barr Foundation and is to support the ongoing research of the Catalyst For a Cure consortium to discover a cure for glaucoma.
RNAi gene silencing technology in form of ophthalmic drops completes Phase 1a clinical trial
July 13th 2010In Spain, the first product based on interference RNA (RNAi) technology is an ophthalmic treatment in the form of drops to treat elevated IOP and glaucoma. SYL040012 has just completed its first clinical trial, having been administered to 30 healthy volunteers.
Leading Chinese KOL puts microkeratomes through their paces
July 12th 2010Professor Ye-Guo Chen, one of the top five key opinion leaders in Chinese refractive surgery has demonstrated a drastic improvement in flap thickness and planarity when using the One Use-Plus SBK microkeratome, defined as 'Sub Bowman's Keratomileusis. '
Implantable telescope finally gets FDA approval
July 9th 2010VisionCare&#;s implantable telescope for end-stage AMD has finally been given FDA approval. The device, discussed in depth in Ophthalmology Times Europe July 2007, was given CE approval three years ago but has subsequently been undergoing rigorous clinical trials in the United States.
Is 'preconditioning' the cornea a new key to transplant success?
July 2nd 2010British and German scientists Dr Claus Cursiefen and his colleagues have reported that transplanted corneas are more likely to fail or be rejected in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, before surgery.